PRAME promotes epithelial-to-mesenchymal transition in triple negative breast cancer (Q60921712)

1

0 references

Adviti Naik

2

0 references

Remy Thomas

3

0 references

Boshra Al-Sulaiti

4

0 references

Shaheen Rizly

Journal of Translational Medicine

5

0 references

language of work or name

English

0 references

publication date

3 January 2019

0 references

published in

0 references

volume

17

0 references

issue

1

0 references

page(s)

9

0 references

copyright license

Creative Commons Attribution 4.0 International

start time

3 January 2019

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

describes a project that uses

ImageJ

1 reference

Europe PubMed Central

11 June 2022

https://www.ebi.ac.uk/europepmc/webservices/rest/PMC6317205/fullTextXML

inferred from PubMed Central ID database lookup

cites work

Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor

1 reference

12 December 2020

Interleukin-1 receptor antagonist mRNA expression and the progression of gastric carcinoma

1 reference

12 December 2020

Molecular portraits of human breast tumours

1 reference

12 December 2020

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

1 reference

12 December 2020

Clinical significance of interleukin-1 receptor antagonist in patients with cervical carcinoma

1 reference

12 December 2020

Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.

1 reference

12 December 2020

Tumor-associated antigen preferentially expressed antigen of melanoma (PRAME) induces caspase-independent cell death in vitro and reduces tumorigenicity in vivo

1 reference

12 December 2020

The human tumor antigen PRAME is a dominant repressor of retinoic acid receptor signaling

1 reference

12 December 2020

Expression of tumor-associated antigens in acute myeloid leukemia: Implications for specific immunotherapeutic approaches

1 reference

12 December 2020

A causal role for the human tumor antigen preferentially expressed antigen of melanoma in cancer

1 reference

12 December 2020

The tetraspanin superfamily member NET-6 is a new tumor suppressor gene

1 reference

12 December 2020

Hypomethylation of PRAME is responsible for its aberrant overexpression in human malignancies

1 reference

12 December 2020

Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers

1 reference

12 December 2020

Prevalence and prognostic and predictive relevance of PRAME in breast cancer

1 reference

12 December 2020

Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancer

1 reference

12 December 2020

JAG1 expression is associated with a basal phenotype and recurrence in lymph node-negative breast cancer

1 reference

12 December 2020

Aberrant hypomethylation of the cancer-testis antigen PRAME correlates with PRAME expression in acute myeloid leukemia

1 reference

12 December 2020

PRAME expression and clinical outcome of breast cancer

1 reference

12 December 2020

Leucine-rich repeat protein PRAME: expression, potential functions and clinical implications for leukaemia

1 reference

12 December 2020

Inhibition of PRAME expression causes cell cycle arrest and apoptosis in leukemic cells

1 reference

12 December 2020

Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies

1 reference

12 December 2020

β-catenin/TCF4 complex induces the epithelial-to-mesenchymal transition (EMT)-activator ZEB1 to regulate tumor invasiveness.

1 reference

12 December 2020

Epithelial-mesenchymal transition: general principles and pathological relevance with special emphasis on the role of matrix metalloproteinases

1 reference

12 December 2020

Expression and prognostic relevance of PRAME in primary osteosarcoma

1 reference

12 December 2020

Epigenetic regulation of PRAME in acute myeloid leukemia is different compared to CD34 cells from healthy donors: Effect of 5-AZA treatment

1 reference

12 December 2020

Global estimates of cancer prevalence for 27 sites in the adult population in 2008.

1 reference

12 December 2020

PRAME expression in head and neck cancer correlates with markers of poor prognosis and might help in selecting candidates for retinoid chemoprevention in pre-malignant lesions.

1 reference

12 December 2020

PRAME/EZH2-mediated regulation of TRAIL: a new target for cancer therapy

1 reference

12 December 2020

Neural crest transcription factor Sox10 is preferentially expressed in triple-negative and metaplastic breast carcinomas.

1 reference

12 December 2020

Knock-down of PRAME increases retinoic acid signaling and cytotoxic drug sensitivity of Hodgkin lymphoma cells

1 reference

12 December 2020

Elevated PRAME expression: what does this mean for treatment of head and neck squamous cell carcinoma?

1 reference

12 December 2020

Differential response to neoadjuvant chemotherapy among 7 triple-negative breast cancer molecular subtypes

1 reference

12 December 2020

Molecular mechanisms of epithelial-mesenchymal transition

1 reference

12 December 2020

PRAME gene expression in childhood acute lymphoblastic leukemia: impact on prognosis

1 reference

12 December 2020

Clinical characteristics and prognostic analysis of triple-negative breast cancer patients

1 reference

12 December 2020

The notch ligand JAGGED1 as a target for anti-tumor therapy

1 reference

12 December 2020

Sox10 Regulates Stem/Progenitor and Mesenchymal Cell States in Mammary Epithelial Cells

1 reference

12 December 2020

Bone Morphogenetic Protein-7 Inhibits EMT-Associated Genes in Breast Cancer

1 reference

12 December 2020

Rates of MAGE-A3 and PRAME expressing tumors in FFPE tissue specimens from bladder cancer patients: potential targets for antigen-specific cancer immunotherapeutics

1 reference

12 December 2020

Diagnostic marker signature for esophageal cancer from transcriptome analysis.

1 reference

12 December 2020

Induction of WNT11 by hypoxia and hypoxia-inducible factor-1α regulates cell proliferation, migration and invasion

1 reference

12 December 2020

PRAME as an Independent Biomarker for Metastasis in Uveal Melanoma

1 reference

12 December 2020

Preferentially Expressed Antigen of Melanoma Prevents Lung Cancer Metastasis

1 reference

12 December 2020

Wnt signaling in cancer.

1 reference

12 December 2020

PRAME is critical for breast cancer growth and metastasis

1 reference

12 December 2020

The prevalence of expression of MAGE-A3 and PRAME tumor antigens in East and South East Asian non-small cell lung cancer patients

1 reference

12 December 2020

GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses.

1 reference

12 December 2020

PRAME as a Potential Target for Immunotherapy in Metastatic Uveal Melanoma.

1 reference

12 December 2020

Impact of Preferentially Expressed Antigen of Melanoma on the Prognosis of Hepatocellular Carcinoma

1 reference

12 December 2020

Inhibiting DNA methylation activates cancer testis antigens and expression of the antigen processing and presentation machinery in colon and ovarian cancer cells

1 reference

12 December 2020

Overexpressed PRAME is a potential immunotherapy target in sarcoma subtypes

1 reference

12 December 2020

Tumor antigen PRAME is up-regulated by MZF1 in cooperation with DNA hypomethylation in melanoma cells

1 reference

12 December 2020

A Comprehensive Immunologic Portrait of Triple-Negative Breast Cancer

1 reference

12 December 2020

Downregulation of PRAME Suppresses Proliferation and Promotes Apoptosis in Hepatocellular Carcinoma Through the Activation of P53 Mediated Pathway

1 reference

12 December 2020

NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives.

1 reference

12 December 2020

Recent Advances in the Treatment of Breast Cancer.

1 reference

12 December 2020